HLA-DR antigens in gastric carcinoma.
Serological HLA typing of 56 gastric carcinoma patients and 53 healthy controls was performed by the long two-stage microlymphocytotoxic test. There was a significantly increased frequency of DR3 antigen (P less than 0.01) in the patients compared to controls. Relative risk analysis revealed a risk of 3.22 for subjects with DR3 antigen for predisposition to gastric carcinoma.
Jayanthi
M
M
Department of Gastroenterology, Osmania General Hospital, Hyderabad, India.
Habibullah
C M
CM
Ishaq
M
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000276:immunology*; D005260:Female; D006684:HLA-DR Antigens / Q000096:biosynthesis*; D006650:Histocompatibility Testing; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000276:immunology*
D006684:HLA-DR Antigens